Autres langues GC Cell Corporation

Actions

A144510

KR7144510005

Installations et services en soins de santé

Cours en clôture Korea S.E. 07/09/2026			Varia. 5j.	Varia. 1 janv.
15 100,00 ^KRW	+2,30%		+11,93%	-39,24%

14/08	GC Cell Corporation publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
15/05	GC Cell Corporation publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Autres langues

14/08	GC Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026
15/05	GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2026
16/03	GC Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2025
14/11	GC Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025
03/11	Gc Cell Q3 operating loss 397 million won
29/10/25	IASO Biotechnology Partners with GC Cell to Bring CAR-T Therapy to Korea
14/08/25	GC Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025
15/05/25	GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2025
30/04/25	Gc Cell Q1 Operating Loss 5.7 Billion Won
21/04/25	DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance Car-T and Car-NK Cell Therapies
17/03/25	GC Cell Corporation Reports Earnings Results for the Full Year Ended December 31, 2024
13/03/25	GC Cell Initiates First Patient Dosing in Phase 1 Clinical Trial for GCC2005, A Promising T-Cell Lymphoma CD5 CAR-NK Therapy
03/12/24	Lotte Biologics Appoints CEO
14/11/24	GC Cell Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024
22/07/24	GC Cell Corporation and Lukas Biomedical Co., Ltd. Announce Strategic Cooperation Agreement to Jointly Tap into the Innovative Cell Therapy Including and Beyond Korean and Taiwan Market
15/07/24	Checkpoint Therapeutics, GC Cell Collaborate on Cancer Research; Shares Rise
15/07/24	GC Cell and Checkpoint Therapeutics Advance Collaborative Cancer Research
20/06/24	GC Cell Signs an MOU with PT Bifarma Adiluhung, an Affiliate of Kalbe Group
29/05/24	GC Cell participates 2024 BIO International Convention, Unveiling its future Blueprint 2.0, as the First Korean Business Forum Sponsor
26/02/24	GC Cell and Biocentriq® Execute Process Transfer Agreement in Anticipation of the U.S. Entry of Immuncell-LC Inj
08/01/24	GC Cell's Promising AB-201 Cancer Treatment to Begin Phase 1 Trials Using Lunit AI Platform
08/01/24	GC Cell Affiliate BioCentriq Secures $29 Million in Funding Round
26/12/23	GC Cell Signs Agreement with Lunit for AI-Powered Cancer Treatment
12/05/23	GC Cell Corporation Reports Earnings Results for the First Quarter Ended March 31, 2023
06/04/23	GC Cell Obtains Anti-Bribery Management System Certification from Korea Compliance Initiative